Optomed has established a subsidiary in the United States of America


24 April 2020 at 9:00

Optomed has established a subsidiary in the United States of America

Optomed has established a subsidiary in the USA and hired a US-based President, Jean-Christophe Firer, to lead Optomed’s commercial operations in the Americas. Firer has over 15 years of experience in leading sales and marketing for ophthalmic devices in the US market. Firer reports to VP Devices, Laura Piila.

Optomed’s strategic plan is to expand its commercial activities in the US market, which was one of the reasons why the company raised funds through the IPO in December 2019. Establishing a subsidiary in the USA enables Optomed to create new business opportunities for its camera and software products, and support US customers better with a local presence.

Optomed CEO, Seppo Kopsala comments: ”Response from the US market has already been very good for our products within several years, and now it is time for us to start systematically investing more in this key market. This is an important step in our growth strategy. With our own subsidiary in the USA, we further improve our opportunities for continued growth in the world’s largest healthcare market.”

Optomed has a long history of selling its handheld fundus cameras in the US market via recognized and prominent OEM-customers Volk Optical Inc., Topcon Medical Systems Inc., Carl Zeiss Meditec Inc. and Haag-Streit. The OEM partnerships are very valuable to Optomed’s business and the company continues to provide full support to these partnerships also in the future while it also develops new business opportunities.

The USA is the world’s largest medical devices market and it covers over 40% of the global fundus camera market, where also Optomed operates in. Optomed’s handheld fundus cameras already have medical device approvals in the USA and Canada, so there are no barriers to expand our business in these markets.

Further enquiries
Seppo Kopsala, CEO, Optomed Plc, +358 40 555 1050, seppo.kopsala@optomed.com

Optomed in Brief

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of over 50 international patents protecting the technology. In 2019, Optomed’s revenue reached EUR 15 million and 2018 pro forma revenue amounted to EUR 14.5 million. At the end of 2019, Optomed employed 108 professionals.